1. Home
  2. HOFT vs CLNN Comparison

HOFT vs CLNN Comparison

Compare HOFT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$13.05

Market Cap

115.9M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.32

Market Cap

120.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
CLNN
Founded
1924
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.9M
120.6M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
HOFT
CLNN
Price
$13.05
$5.32
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$32.67
AVG Volume (30 Days)
32.2K
110.3K
Earning Date
12-11-2025
11-13-2025
Dividend Yield
3.58%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$375,494,000.00
$214,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.25
$82.05
P/E Ratio
N/A
N/A
Revenue Growth
13.82
N/A
52 Week Low
$7.34
$2.28
52 Week High
$13.85
$13.50

Technical Indicators

Market Signals
Indicator
HOFT
CLNN
Relative Strength Index (RSI) 67.32 41.56
Support Level $10.94 $4.68
Resistance Level $13.47 $5.40
Average True Range (ATR) 0.56 0.58
MACD 0.12 0.02
Stochastic Oscillator 74.36 37.61

Price Performance

Historical Comparison
HOFT
CLNN

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: